• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年心力衰竭中国患者预后风险评分的表现。

Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.

机构信息

Department of Cardiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

出版信息

Clin Interv Aging. 2021 Sep 16;16:1669-1677. doi: 10.2147/CIA.S323979. eCollection 2021.

DOI:10.2147/CIA.S323979
PMID:34556979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8453434/
Abstract

PURPOSE

Elderly heart failure (HF) patients have different clinical characteristics and poorer prognosis compared with younger patients. Prognostic risk scores for HF have not been validated well in elderly patients. We aimed to validate the Seattle Heart Failure Model (SHFM) and the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) score in an elderly Chinese HF cohort.

PATIENTS AND METHODS

This retrospective study enrolled 675 elderly HF patients (age≥70 years) discharged from our hospital between 2012 and 2017. The performance of the two risk scores was evaluated in terms of discrimination, using receiver-operating characteristic analysis, and calibration using a calibration plot and Hosmer-Lemeshow (H-L) test. Absolute risk reclassification was used to compare the two scores.

RESULTS

During the mean follow-up time of 32.6 months, 193 patients (28.6%) died, and 1-year mortality was 10.5%. The predicted median 1-year mortality was 8% for the SHFM and 18% for the MAGGIC score. A Kaplan-Meier survival curve demonstrated that event rates of all-cause mortality significantly increased with increasing SHFM and MAGGIC scores. The discriminatory capacity of the SHFM was greater than that of the MAGGIC score (c-statistics were 0.72 and 0.67, respectively; P = 0.05). The calibration plot for the SHFM was better than that for MAGGIC score for 1-year mortality (SHFM: H-L χ =8.2, P = 0.41; MAGGIC: H-L χ =18.8, P =0.02). Compared with the MAGGIC score, the net reclassification index (NRI) of the SHFM was 2.96% (Z=5.88, P< 0.0001).

CONCLUSION

The SHFM performs better than MAGGIC score, having good discrimination, calibration and risk classification for the prediction of 1-year mortality in elderly Chinese HF patients.

摘要

目的

与年轻患者相比,老年心力衰竭(HF)患者具有不同的临床特征和较差的预后。HF 的预后风险评分尚未在老年患者中得到很好的验证。我们旨在验证西雅图心力衰竭模型(SHFM)和荟萃分析全球慢性心力衰竭组(MAGGIC)评分在老年中国 HF 队列中的表现。

患者和方法

这项回顾性研究纳入了 2012 年至 2017 年期间我院出院的 675 名年龄≥70 岁的老年 HF 患者。使用受试者工作特征(ROC)分析评估了两种风险评分的区分能力,使用校准图和 Hosmer-Lemeshow(H-L)检验评估了校准能力。使用绝对风险再分类比较了两种评分。

结果

在平均 32.6 个月的随访期间,193 名患者(28.6%)死亡,1 年死亡率为 10.5%。SHFM 预测的 1 年中位死亡率为 8%,MAGGIC 评分预测的 1 年死亡率为 18%。Kaplan-Meier 生存曲线表明,全因死亡率的事件发生率随着 SHFM 和 MAGGIC 评分的增加而显著增加。SHFM 的区分能力大于 MAGGIC 评分(C 统计量分别为 0.72 和 0.67,P = 0.05)。SHFM 的校准图优于 MAGGIC 评分的 1 年死亡率校准图(SHFM:H-L χ =8.2,P = 0.41;MAGGIC:H-L χ =18.8,P = 0.02)。与 MAGGIC 评分相比,SHFM 的净重新分类指数(NRI)为 2.96%(Z=5.88,P<0.0001)。

结论

SHFM 优于 MAGGIC 评分,对中国老年 HF 患者 1 年死亡率的预测具有良好的区分度、校准度和风险分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/4f090d0c48da/CIA-16-1669-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/479b3d84b3d5/CIA-16-1669-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/892dbd2872df/CIA-16-1669-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/40a5f8a13bfc/CIA-16-1669-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/1d314c700fe5/CIA-16-1669-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/4f090d0c48da/CIA-16-1669-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/479b3d84b3d5/CIA-16-1669-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/892dbd2872df/CIA-16-1669-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/40a5f8a13bfc/CIA-16-1669-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/1d314c700fe5/CIA-16-1669-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d7/8453434/4f090d0c48da/CIA-16-1669-g0005.jpg

相似文献

1
Performance of Prognostic Risk Scores in Elderly Chinese Patients with Heart Failure.老年心力衰竭中国患者预后风险评分的表现。
Clin Interv Aging. 2021 Sep 16;16:1669-1677. doi: 10.2147/CIA.S323979. eCollection 2021.
2
Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist?心力衰竭患者预后风险评分的表现:是否存在性别差异?
Can J Cardiol. 2020 Jan;36(1):45-53. doi: 10.1016/j.cjca.2019.08.021. Epub 2019 Aug 22.
3
Validation of the Meta-Analysis Global Group in Chronic Heart Failure risk score for the prediction of 1-year mortality in a Chinese cohort.验证 Meta-Analysis Global Group 在慢性心力衰竭风险评分中的应用,以预测中国队列患者的 1 年死亡率。
Chin Med J (Engl). 2022 Dec 5;135(23):2829-2835. doi: 10.1097/CM9.0000000000002026.
4
Head-to-head comparison of contemporary heart failure risk scores.当代心力衰竭风险评分的头对头比较。
Eur J Heart Fail. 2021 Dec;23(12):2035-2044. doi: 10.1002/ejhf.2352. Epub 2021 Oct 1.
5
Performance of risk models to predict mortality risk for patients with heart failure: evaluation in an integrated health system.风险模型预测心力衰竭患者死亡风险的性能:在综合卫生系统中的评估。
Clin Res Cardiol. 2024 Sep;113(9):1343-1354. doi: 10.1007/s00392-024-02433-2. Epub 2024 Apr 2.
6
Differential prognostic accuracy of right ventricular dysfunction, the Seattle heart failure model and the MAGGIC score in patients with severe mitral regurgitation undergoing the MitraClip® procedure.右心室功能障碍、西雅图心力衰竭模型及MAGGIC评分对接受MitraClip®手术的严重二尖瓣反流患者的预后预测准确性差异
Int J Cardiol Heart Vasc. 2020 Oct 12;31:100641. doi: 10.1016/j.ijcha.2020.100641. eCollection 2020 Dec.
7
Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.Meta-Analysis Global Group in Chronic (MAGGIC) 心力衰竭风险评分:验证一种简单工具预测射血分数保留的心力衰竭患者的发病率和死亡率的有效性。
J Am Heart Assoc. 2018 Oct 16;7(20):e009594. doi: 10.1161/JAHA.118.009594.
8
Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.验证 MAGGIC(慢性心力衰竭全球荟萃分析协作组)心力衰竭风险评分以及添加利钠肽对住院心力衰竭患者出院后死亡率预测的影响。
PLoS One. 2018 Nov 28;13(11):e0206380. doi: 10.1371/journal.pone.0206380. eCollection 2018.
9
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.欧洲心脏病学会心力衰竭长期注册研究中纳入的慢性心力衰竭患者预后风险评分的表现。
JACC Heart Fail. 2018 Jun;6(6):452-462. doi: 10.1016/j.jchf.2018.02.001.
10
Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.预测射血分数降低的心力衰竭门诊患者 1 年死亡率:经验模型是否优于医生的直观估计?一项多中心队列研究。
Circ Heart Fail. 2023 Jul;16(7):e010312. doi: 10.1161/CIRCHEARTFAILURE.122.010312. Epub 2023 Jun 20.

引用本文的文献

1
Cost-Effectiveness of Left Ventricular Assist Device for Transplant-Ineligible Patients.左心室辅助装置用于不符合移植条件患者的成本效益分析
JAMA Netw Open. 2025 Apr 1;8(4):e254483. doi: 10.1001/jamanetworkopen.2025.4483.

本文引用的文献

1
Epidemiology of heart failure.心力衰竭的流行病学。
Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1.
2
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.射血分数降低的心力衰竭中衰弱的流行和重要性——PARADIGM-HF 和 ATMOSPHERE 分析。
Eur J Heart Fail. 2020 Nov;22(11):2123-2133. doi: 10.1002/ejhf.1832. Epub 2020 Apr 30.
3
Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study.
老年慢性心力衰竭患者的临床特征及预后因素——CHART-2研究报告
Int J Cardiol Heart Vasc. 2020 Mar 20;27:100497. doi: 10.1016/j.ijcha.2020.100497. eCollection 2020 Apr.
4
Performance of Prognostic Risk Scores in Heart Failure Patients: Do Sex Differences Exist?心力衰竭患者预后风险评分的表现:是否存在性别差异?
Can J Cardiol. 2020 Jan;36(1):45-53. doi: 10.1016/j.cjca.2019.08.021. Epub 2019 Aug 22.
5
Validity of the Seattle Heart Failure Model after heart failure hospitalization.心力衰竭住院后西雅图心力衰竭模型的有效性。
ESC Heart Fail. 2019 Jun;6(3):509-515. doi: 10.1002/ehf2.12427. Epub 2019 Mar 1.
6
Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.验证 MAGGIC(慢性心力衰竭全球荟萃分析协作组)心力衰竭风险评分以及添加利钠肽对住院心力衰竭患者出院后死亡率预测的影响。
PLoS One. 2018 Nov 28;13(11):e0206380. doi: 10.1371/journal.pone.0206380. eCollection 2018.
7
Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.Meta-Analysis Global Group in Chronic (MAGGIC) 心力衰竭风险评分:验证一种简单工具预测射血分数保留的心力衰竭患者的发病率和死亡率的有效性。
J Am Heart Assoc. 2018 Oct 16;7(20):e009594. doi: 10.1161/JAHA.118.009594.
8
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.基于证据的心力衰竭药物治疗的处方模式和 ASIAN-HF 注册研究的结果:一项队列研究。
Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.
9
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry.欧洲心脏病学会心力衰竭长期注册研究中纳入的慢性心力衰竭患者预后风险评分的表现。
JACC Heart Fail. 2018 Jun;6(6):452-462. doi: 10.1016/j.jchf.2018.02.001.
10
Sex Differences in Left Ventricular Cavity Dilation and Outcomes in Acute Heart Failure Patients With Left Ventricular Systolic Dysfunction.左心室收缩功能障碍的急性心力衰竭患者中左心室腔扩张与结局的性别差异。
Can J Cardiol. 2018 Apr;34(4):477-484. doi: 10.1016/j.cjca.2018.01.019. Epub 2018 Jan 31.